Skip to main content
Fig. 9 | BMC Cancer

Fig. 9

From: Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma

Fig. 9

IPS and immunotherapy gene expression analysis. The levels of immune checkpoints molecules including PD- L1 (A), PD-1 (B), CTLA-4 (C), TIM-3 (D), LAG-3 (E), and TIGIT (F) in low-risk and high-risk groups. The association between IPS and the m6Ascore in PAAD patients based on TCIA database, H CTLA4 PD1 I CTLA4 PD1+ J CTLA4+ PD1 CTLA4+PD1+

Back to article page